Barbiturate detection in oral fluid, plasma, and urine

Therapeutic Drug Monitoring

Volumn 33, Issue 1, 2011, Pages 72-79

  Fritch, Dean ^a   Blum, Kristen ^a   Nonnemacher, Sheena ^a   Kardos, Keith ^a   Buchhalter, August R ^b   Cone, Edward J ^c  

^a ORASURE TECHNOLOGIES INC   (United States)

^b PINNEY ASSOCIATES   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

barbiturates; detection; Intercept; oral fluid; plasma; saliva; urine

Indexed keywords

BUTALBITAL; PHENOBARBITAL; SECOBARBITAL;

ADULT; ARTICLE; BLOOD ANALYSIS; BODY FLUID; DIZZINESS; DROWSINESS; DRUG BLOOD LEVEL; DRUG DISPOSITION; DRUG EXCRETION; DRUG SALIVA LEVEL; DRUG URINE LEVEL; FEMALE; GAS CHROMATOGRAPHY; HUMAN; LIQUID CHROMATOGRAPHY; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SINGLE DRUG DOSE; SOMNOLENCE; TANDEM MASS SPECTROMETRY; URINALYSIS; VEIN PUNCTURE;

ADMINISTRATION, ORAL; ADULT; BARBITURATES; BODY FLUIDS; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH; PHENOBARBITAL; SECOBARBITAL; SUBSTANCE ABUSE DETECTION; YOUNG ADULT;

EID: 78751649641     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0b013e3182018151     Document Type: Article

References (18)

1. Lopez-Munoz F, Ucha-Udabe R, Alamo C. The history of barbiturates a century after their clinical introduction. Neuropsychiatr Dis Treat. 2005; 1:329-343.
2. Coupey SM. Barbiturates. Pediatr Rev. 1997;18:260-264.
3. Substance Abuse and Mental Health Administration OOAS. National Estimates of Drugrelated Emergency Department Visits. 2007. Rock-ville, MD: Drug Abuse Warning Network; 2010.
4. Fritch D, Blum K, Nonnemacher S, et al. Identification and quantitation of amphetamines, cocaine, opiates, and phencyclidine in oral fluid by liquid chromatography-tandem mass spectrometry. J Anal Toxicol. 2009;33: 569-577.
5. Morgan WW. Abuse liability of barbiturates and other sedative-hypnotics. Adv Alcohol Subst Abuse. 1990;9:67-82.
6. Mucklow JC, Bending MR, Kahn GC, et al. Drug concentration in saliva. Clin Pharmacol Ther. 1978;24:563-570.
7. Blom GF, Guelen PJM. The distribution of anti-epileptic drugs between serum, saliva and cerebrospinal fluid. In: Gardner-Thorpe C, Janz D, Meinardi H, et al, eds. Antiepileptic Drug Monitoring. Tallahassee, FL: Pitman Medical; 1977:287-297.
8. Inaba T, Kalow W. Salivary excretion of amobarbital in man. Clin Pharmacol Ther. 1975;18:558-562.
9. Goldsmith RF, Ouvrier RA. Salivary anticonvulsant levels in children: a comparison of methods. Ther Drug Monit. 1981;3:151-157.
10. Cook CE, Amerson E, Poole WK, et al. Phenytoin and phenobarbital concentrations in saliva and plasma measured by radioimmunoassay. Clin Pharmacol Ther. 1975;18:742-747.
11. Mucklow JC, Bacon CJ, Hierons AM, et al. Monitoring of phenobarbitone and phenytoin therapy in small children by salivary samples. Ther Drug Monit. 1981;3:275-277.
12. Nishihara K, Uchino K, Saitoh Y, et al. Estimation of plasma unbound phenobarbital concentration by using mixed saliva. Epilepsia. 1979;20:37-45.
13. Tokugawa K, Ueda K, Fujito H, et al. Correlation between the saliva and free serum concentration of phenobarbital in epileptic children. Eur J Pediatr. 1986;145:401-402.
14. Sobaniec W. A correlation between the levels of phenobarbital, phenytoin and valproic acid in the blood serum and in saliva from children treated due to epilepsy. Mater Med Pol. 1989;21:323-326.
15. Knott C, Reynolds F. The place of saliva in antiepileptic drug monitoring. Ther Drug Monit. 1984;6:35-41.
16. Wille SM, Raes E, Lillsunde P, et al. Relationship between oral fluid and blood concentrations of drugs of abuse in drivers suspected of driving under the influence of drugs. Ther Drug Monit. 2009;31:511-519.
17. Schmidt D, Kupferberg HJ. Diphenylhydantoin, phenobarbital, and primidone in saliva, plasma and cerebrospinal fluid. Epilepsia. 1975; 16:735-741.
18. Baselt RC. Disposition of Toxic Drugs and Chemicals in Man. Foster City, CA: Biomedical Publications; 2004.